Chesapeake Wealth Management Bristol Myers Squibb CO Transaction History

Chesapeake Wealth Management

$273 Million
Q1 2024

A detailed history of Chesapeake Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chesapeake Wealth Management holds 16,192 shares of BMY stock, worth $661,605. This represents 0.32% of its overall portfolio holdings.

Number of Shares

16,192

Previous 19,904 18.65%

Holding current value

$661,605

Previous $1.02 Million 14.01%

% of portfolio

0.32%

Previous 0.4%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $178,101 - $201,932	-3,712 Reduced 18.65%	16,192 $878,000
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $39,608 - $47,263	-817 Reduced 3.94%	19,904 $1.02 Million
Q3 2023 Nov 16, 2023	SELL	$57.89 - $64.73 $30,218 - $33,789	-522 Reduced 2.46%	20,721 $1.2 Million
Q2 2023 Aug 01, 2023	BUY	$63.71 - $70.74 $11,276 - $12,520	177 Added 0.84%	21,243 $1.36 Million
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $68,601 - $77,809	1,044 Added 5.21%	21,066 $1.46 Million

Q4 2022 Feb 23, 2023	BUY	$68.48 - $81.09 $48,620 - $57,573	710 Added 3.68%	20,022 $1.44 Million
Q3 2022 Oct 28, 2022	BUY	$0.13 - $76.84 $682 - $403,486	5,251 Added 37.34%	19,312 $1.37 Million
Q2 2022 Jul 21, 2022	SELL	$72.62 - $79.98 $6,027 - $6,638	-83 Reduced 0.59%	14,061 $1.08 Million
Q1 2022 Apr 19, 2022	SELL	$61.48 - $73.72 $35,228 - $42,241	-573 Reduced 3.89%	14,144 $1.03 Million
Q4 2021 Feb 03, 2022	SELL	$53.63 - $62.52 $92,940 - $108,347	-1,733 Reduced 10.53%	14,717 $918,000
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $192,243 - $225,188	-3,249 Reduced 16.49%	16,450 $973,000
Q2 2021 Jul 29, 2021	SELL	$61.91 - $67.42 $147,098 - $160,189	-2,376 Reduced 10.76%	19,699 $1.32 Million
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $683,596 - $768,844	-11,520 Reduced 34.29%	22,075 $1.39 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $137,017 - $155,265	2,373 Added 7.6%	33,595 $2.08 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $32,620 - $36,147	-568 Reduced 1.79%	31,222 $1.88 Million
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $11,073 - $12,946	202 Added 0.64%	31,790 $1.87 Million
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $40,971 - $59,540	883 Added 2.88%	31,588 $1.76 Million
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $553,760 - $722,330	11,253 Added 57.85%	30,705 $1.97 Million
Q3 2019 Oct 25, 2019	BUY	$42.77 - $50.71 $209,915 - $248,884	4,908 Added 33.75%	19,452 $986,000
Q2 2019 Aug 01, 2019	BUY	$44.62 - $49.34 $68,759 - $76,032	1,541 Added 11.85%	14,544 $660,000
Q1 2019 Apr 17, 2019	SELL	$45.12 - $53.8 $22,560 - $26,900	-500 Reduced 3.7%	13,003 $620,000
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $27,305 - $35,408	-560 Reduced 3.98%	13,503 $702,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $29,968 - $33,801	-543 Reduced 3.72%	14,063 $873,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $35,371 - $44,086	-700 Reduced 4.57%	14,606 $809,000
Q1 2018 Jun 04, 2018	BUY	$59.92 - $68.98 $917,135 - $1.06 Million	15,306 New	15,306 $968,000

Others Institutions Holding BMY

# of Institutions

2,557

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Wealth Management with notifications on news.

Account

Chesapeake Wealth Management Bristol Myers Squibb CO Transaction History